Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR Trial: SCRT + Toripalimab + FOLFOX vs LCRT + FOLFOX in Rectal Adenocarcinoma
NCT07669220Phase 2Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in rectal adenocarcinoma, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Started Jan 2026; status: recruiting.
02
Drugs
toripalimab
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT07669220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07669220.